Clinical Pharmacology |
From inside the book
Results 1-3 of 40
Page 49
... Hypertension . Phenoxybenzamine and phentolamine have little place in the management of essential hypertension , largely due to their other unwanted and unpleasant pharmacologi- cal actions . Prazosin , however , is now established in ...
... Hypertension . Phenoxybenzamine and phentolamine have little place in the management of essential hypertension , largely due to their other unwanted and unpleasant pharmacologi- cal actions . Prazosin , however , is now established in ...
Page 56
... hypertension in the future . Although of little value in the management of essential hypertension , sedative and tranquillizing drugs such as ben- zodiazepines may reduce tension and anxiety and prevent excessive increases in blood ...
... hypertension in the future . Although of little value in the management of essential hypertension , sedative and tranquillizing drugs such as ben- zodiazepines may reduce tension and anxiety and prevent excessive increases in blood ...
Page 57
... hypertension who have failed to respond adequately to first - line treatment ( p . 48 ) . ẞ - receptor blocking drugs are now considered by many physicians to be the firstline treatment in essential hypertension as well as in protecting ...
... hypertension who have failed to respond adequately to first - line treatment ( p . 48 ) . ẞ - receptor blocking drugs are now considered by many physicians to be the firstline treatment in essential hypertension as well as in protecting ...
Contents
The assessment of new drugs | 1 |
Factors influencing the action of drugs | 9 |
Adverse effects of drugs | 18 |
Copyright | |
20 other sections not shown
Common terms and phrases
absorbed absorption acetylcholine action activity acute administration adrenaline adrenergic adverse effects agents amines anaemia analgesic anti anti-inflammatory antibiotics anticholinergic anticoagulants antidepressants antihistamine aspirin barbiturates benzodiazepine blockade blocking drugs blood pressure bowel cardiac catecholamines cause cells central chronic clinical compounds concentration deficiency depression derivatives diabetes diarrhoea digitalis digoxin disease diuretic dopamine dosage doses dysrhythmias enzyme excretion folic acid gastric gastrointestinal given guanethidine histamine hormone hypertension hypnotic hypokalaemia hypotension increase infections inhibit inhibitors insulin intravenous levodopa liver membrane metabolism metabolites monoamine morphine muscle myocardial nausea nerve neurone noradrenaline occur oestrogen oral overdosage pain parenterally particularly patients penicillin peripheral pethidine pharmacological phenobarbitone phenothiazines phenytoin plasma platelet potassium potent preparations produce properties propranolol prostaglandins protein receptor reduce release renal reserpine respiratory result serum level sodium soluble ẞ-receptor steroids stimulation substances sulphonamides sympathetic syndrome synthesis synthetic therapeutic therapy thyroid tion tissue toxic transmitter treated treatment trial tubule urinary urine usually vitamin vomiting